SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001541487-13-000005
Filing Date
2013-07-16
Accepted
2013-07-16 21:17:21
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1566
  Complete submission text file 0001541487-13-000005.txt   3037
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address
McGowan Dana S. (Reporting) CIK: 0001581060 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 13971388